View Section: Financials
LAVA Medtech Statements
LV
LAVA Medtech Income Statement
B
M
USD (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
2022-12-31
%
—
100
—
0
—
0
—
0
0.378
0
0.378
0
-0.378
0
1.739
0
—
0
1.361
0
0.188
0
1.172
0
0.082
14.375
2022-09-30
%
—
100
—
0
—
0
—
0
0.382
0
0.382
0
-0.382
0
0.944
0
—
0
0.562
0
0.101
0
0.461
0
0.032
14.375
2022-06-30
%
—
100
—
0
—
0
—
0
0.345
0
0.345
0
-0.345
0
2.121
0
0
0
1.776
0
0.024
0
1.752
0
0.122
14.375
2022-03-31
%
—
100
—
0
—
0
—
0
0.455
0
0.455
0
-0.455
0
1.565
0
—
0
1.11
0
-0.009
0
1.119
0
0.078
14.375
2021-12-31
%
—
100
—
0
—
0
—
0
0.291
0
0.291
0
-0.291
0
18.347
0
-0.097
0
17.958
0
-0.019
0
17.977
0
1.251
14.375
2021-09-30
%
—
100
—
0
—
0
—
0
0.005
0
0.005
0
-0.005
0
—
0
—
0
-0.005
0
—
0
-0.005
0
0
12.5
2021-06-30
%
—
100
—
0
—
0
—
0
0.001
0
0.001
0
-0.001
0
—
0
—
0
-0.001
0
—
0
-0.001
0
0
12.5
View Section: Balance Sheet